Licensing Update

RNS Number:2206D
Healthcare Enterprise Group PLC
04 September 2007




4 September 2007

Healthcare Enterprise Group PLC

Ebiox TruKleen U.S. licensing update


Healthcare Enterprise Group PLC ("HCEG" or "the Group", AIM: HCEG), the
international healthcare products group, is publishing an update regarding the
licensing arrangements for its Ebiox TruKleen products across the U.S. states.
In April 2007 the Group secured U.S. Environment Protection Agency ("EPA")
approval for Ebiox. The licensing programme, which comprises applications for
individual U.S. state approvals, is progressing well and in line with the
Board's expectations.

Ebiox TruKleen is the registered trade name of the Ebiox surface hygiene
products in the U.S.  The Ebiox TruKleen product family comprises wipes, spray
and concentrate which are now licenced in the United States as follows:  Wipes
49 States, Spray 46 States and Concentrate 44 States. The Group expects to
complete all licensing by the end of September 2007.



Enquiries:

Healthcare Enterprise Group                            + 44 (0)1925 898 200
Lyndon Gaborit, Executive Deputy Chairman

Numis Securities
David Poutney                                          [phone]

College Hill                                           [phone]
Adrian Duffield / Jon Davies



Notes to editors

Healthcare Enterprise Group PLC - is a business engaged in medical product
distribution, occupational health, and first aid markets.  These businesses
underpin a range of innovative medical devices. HCEG is listed on the
Alternative Investment Market (AIM) of the London Stock Exchange.

Ebiox - Patented decontamination and disinfectant products that are safe and
alcohol free but substantially more effective than conventional methods at
destroying embedded microorganisms. The Ebiox range includes hand hygiene
products, surface disinfectants, products to clean and decontaminate surgical
instruments, and dental cleaning products. Trukleen, the registered trade name
of the Ebiox surface hygiene products in the U.S., offers significant advantages
over other surface cleaners in the U.S. market. By removing biofilm and cleaning
to the molecular level, Trukleen is effective against pathogens including
viruses, fungi and bacteria such as MRSA. Trukleen is free of damaging chemicals
and skin irritants such as alcohols, phenols, chlorine and aldehydes. It is
therefore well suited for repeated use on washable surfaces over protracted
periods of time.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCBRGDCBXGGGRX